Risperidone: Review of Its Therapeutic Utility in Depression
Risperidone: Review of Its Therapeutic Utility in Depression By Joyce E. Myers, MD, and Michael E. Thase, MD
Need a new search?
If you didn't find what you were looking for, try a new search!
A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors
A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors By Mikael Landén, MD, PhD, and Michael E. Thase, MD
Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening
Robert MA Hirschfeld Link ORIGINAL RESEARCH Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening Robert MA Hirschfeld,MD, Joseph R. Calabrese, MD, Mark A. Frye,MD, Philip W. Lavori, PhD, Gary Sachs,MD, Michael E. Thase,MD, and Karen Dineen Wagner,MD, PhD
Madhukar H. Trivedi – Research Evaluating the Value of Augmenting Medication with Psychotherapy:Rationale and Design
Madhukar H. Trivedi Link ORIGINAL RESEARCH REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: Rationale and Design Madhukar H. Trivedi, James H. Kocsis, Michael E. Thase, David W. Morris, Stephen R. Wisniewski, Andrew C. Leon, Alan J. Gelenberg, Daniel N. Klein, George Niederehe, Alan F. Schatzberg, Philip T. Ninan, Martin B. [...]
Laszlo Gyulai – Correlates of Functioning in Bipolar Disorder
Laszlo Gyulai Link EVIDENCE-BASED MEDICINE Correlates of Functioning in Bipolar Disorder Laszlo Gyulai, Mark S. Bauer, Lauren B. Marangell, Ellen B. Dennehy, Michael E. Thase, Michael W. Otto, Hongwei Zhang, Stephen R. Wisniewski, David J. Miklowitz, Mark H. Rapaport, Claudia F. Baldassano, and Gary S. Sachs for the STEP-BD Investigators
Author Guidelines
Author's Guidelines 2024 Aims and Scope Psychopharmacology Bulletin publishes full-length research articles, review articles, brief reports, clinical case studies, commentary, and letters. Manuscripts submitted to Bulletin’s new section, Negative and Failed Clinical Trial Reports will be entitled to fast-track review. Psychopharmacology Bulletin is committed to the highest ethical [...]
A Systematic Review of Augmentation Strategies for Major Depressive Disorder
GENERAL PSYCHIATRY A Systematic Review of Augmentation Strategies for Patients with Major Depressive Disorder Rachael Fleurence, Rebecca Williamson, Yonghua Jing, Edward Kim, Quynh-Van Tran, Andrei Pikalov, Michael E. Thase
Assessing Rates and Predictors of Tachyphylaxis
ORIGINAL RESEARCH Assessing Rates and Predictors of Tachyphylaxis During the Prevention of Recurrent Episodes of Depression With Venlafaxine ER for Two Years (PREVENT) Study Anthony J. Rothschild, Boadie W. Dunlop, David L. Dunner, Edward S. Friedman, Alan Gelenberg, Peter Holland, James H. Kocsis, Susan G. Kornstein, Richard Shelton, Madhukar H. [...]
Psychopharmacology Bulletin
Psychopharmacology Bulletin is indexed in Index Medicus, EMBASE/Excerpta Medica, Psychological Abstracts, EBSCO, Current Contents, Science Citation Index, SCOPUS, Thompson/Reuters and Biological Abstracts under Psychopharmacol Bull. Psychopharmacology Bulletin (ISSN# 2472-2448 - Former ISSN# 0048-5764) is a peer-reviewed journal available through subscription only. Permission to reproduce articles [...]
About – MedWorks Media
MedWorks Media - We Know Psychiatry MedWorks Media Inc. is a digital & print publisher of some of the most prominent science education journals and special educational projects, which circulate to more psychiatrists, psychopharmacologists, and the larger medical community than any other publisher in the field. Medworks' [...]
Psychopharmacology Bulletin Newsletter 4
• ORIGINAL RESEARCH • EVIDENCE BASED MEDICINE • GENERAL PSYCHIATRY Seroquel Once a Day: A Randomized, Double-Blind, Placebo-Controlled Study— This 6-week, randomized, double-blind study aimed to demonstrate efficacy of once-daily extended release quetiapine fumarate (quetiapine XR) versus placebo in patients with acute schizophrenia resulting in the efficacy of quetiapine XR [...]
Psychopharmacology Bulletin Newsletter 2
Newsletter No. 2, 2008 www.psychopharmbulletin.com Volume 41 • Number 2 • 2008 Psychopharmacology BULLETIN Newsletter the advance newsletter of Psychopharmacology BULLETIN Summary—Index of This Issue On-Press • ORIGINAL RESEARCH • EVIDENCE BASED MEDICINE Are SNRIs More Effective than SSRIs? A Review of the Current State of the Controversy—p.2 [...]
Psychopharmacology Bulletin Newsletter 1
• ORIGINAL RESEARCH • EVIDENCE BASED MEDICINE ORIGINAL RESEARCH: The Trials and Travails Placebo-Controlled — PTSD Double-Blind — ADHD Pilot-Controlled — GAD Comparative Analysis — ANTIDEPRESSANT TRIALS A Placebo-Controlled Trial of Guanfacine for the Treatment of PTSD in Veterans —p.2 Lori Davis, MD, L. Charles Ward, PhD, Ann Rasmusson, MD, [...]
Psychopharmacology Bulletin Newsletter 4
THE ADVANCE NEWSLETTER OF PSYCHOPHARMACOLOGY BULLETIN Summary—Index of This Issue On-Press Newsletter No. 4, 2007 www.psychopharmbulletin.com Volume 40 • Number 3 • 2007 This newsletter is a synopsis of topical issues to be published in Psychopharmacology Bu l l e t i n. It is provided as a free service [...]
Psychopharmacology Bulletin Newsletter 5
THE ADVANCE NEWSLETTER OF PSYCHOPHARMACOLOGY BULLETIN Summary—Index of This Issue On-Press Newsletter No. 5, 2007 www.psychopharmbulletin.com Volume 40 • Number 3 • 2007 This newsletter is a synopsis of topical issues to be published in Psychopharmacology Bu l l e t i n. It is provided as a free service [...]
EDITORIALS
EDITOR’S NOTE The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry By Michael E. Thase, MD It is both an honor and a ch a llenge to assume the helm as editor of P sy ch o p h a rm ac o l [...]